Point mutations abolish 11 beta-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess. (Q41198126)
Jump to navigation
Jump to search
scientific article published on May 1996
Language | Label | Description | Also known as |
---|---|---|---|
English | Point mutations abolish 11 beta-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess. |
scientific article published on May 1996 |
Statements
Point mutations abolish 11 beta-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess (English)
V R Obeyesekere
K Li
R C Wilson
M I New
J W Funder
Z S Krozowski